NCT06195046View on ClinicalTrials.gov

Baroreflex Activation Therapy in Left Ventricular Assist Device Patients Study

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 1, 2025

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2025

Conditions
Congestive Heart Failure
Interventions
DEVICE

Baroreflex Activation Therapy (BAT)

activation of BAROSTIM NEO system that affects autonomic modulation with BAT therapy.

Sponsors

Collaborators (1)

CVRx, Inc.
All Listed Sponsors
collaborator

CVRx, Inc.

INDUSTRY

lead

Medical University of South Carolina

OTHER

NCT06195046 - Baroreflex Activation Therapy in Left Ventricular Assist Device Patients Study | Biotech Hunter | Biotech Hunter